{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T17:03:00Z","timestamp":1784394180198,"version":"3.55.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T00:00:00Z","timestamp":1782000000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Otolaryngology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.amjoto.2026.104871","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T06:47:29Z","timestamp":1782283649000},"page":"104871","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The inflammatory microenvironment in patients with advanced and relapsing hypopharyngeal squamous cell carcinoma"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9756-4993","authenticated-orcid":false,"given":"Anna-Rebekka","family":"Staufenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias M.","family":"Gaida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudine","family":"Graf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justus","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Matthias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haralampos","family":"Gouveris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjoto.2026.104871_bb0005","series-title":"Surveillance Research Program, National Cancer Institute","article-title":"SEER*Explorer: An interactive website for SEER cancer statistics [Internet]","year":"2025"},{"key":"10.1016\/j.amjoto.2026.104871_bb0010","series-title":"International Agency for Research on Cancer","year":"2024"},{"key":"10.1016\/j.amjoto.2026.104871_bb0015","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1007\/s00405-018-4997-1","article-title":"Cancer stage and pack-years, but not p16 or HPV, are relevant for survival in hypopharyngeal and laryngeal squamous cell carcinomas","volume":"275","author":"Dahm","year":"2018","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.amjoto.2026.104871_bb0020","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1093\/annonc\/mdx304","article-title":"Human papillomavirus-related oropharyngeal cancer","volume":"28","author":"Taberna","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.amjoto.2026.104871_bb0025","doi-asserted-by":"crossref","first-page":"6060","DOI":"10.3390\/cancers13236060","article-title":"Trends in treatment of head and neck Cancer in Germany: a diagnosis-related-groups-based Nationwide analysis, 2005\u20132018","volume":"13","author":"Hermanns","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.amjoto.2026.104871_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-019-5412-z","article-title":"Comparative efficacy of six therapies for hypopharyngeal and laryngeal neoplasms: a network meta-analysis","volume":"19","author":"Che","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.amjoto.2026.104871_bb0035","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/jso.26440","article-title":"Survival and complications with a surgical approach in advanced hypopharyngeal cancer","volume":"123","author":"Galeano Machuca","year":"2021","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.amjoto.2026.104871_bb0040","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1159\/000524870","article-title":"The prognostic capacity of systemic inflammation response index, neutrophil-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, and platelet-to-lymphocyte ratio in patients with Hypopharyngeal squamous cell carcinoma","volume":"84","author":"Wang","year":"2022","journal-title":"ORL"},{"key":"10.1016\/j.amjoto.2026.104871_bb0045","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.amjoto.2026.104871_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygeno.2023.110691","article-title":"A tumor-associated macrophages related model for predicting biochemical recurrence and tumor immune environment in prostate cancer","volume":"115","author":"Chen","year":"2023","journal-title":"Genomics"},{"key":"10.1016\/j.amjoto.2026.104871_bb0055","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00262-018-2289-7","article-title":"Immune cell infiltration as a biomarker for the diagnosis and prognosis of stage I\u2013III colon cancer","volume":"68","author":"Zhou","year":"2019","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.amjoto.2026.104871_bb0060","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1080\/21645515.2016.1199310","article-title":"Pembrolizumab (Keytruda)","volume":"12","author":"Kwok","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.amjoto.2026.104871_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2022.188762","article-title":"Tumor-associated neutrophils and neutrophil-targeted cancer therapies","volume":"1877","author":"Que","year":"2022","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10.1016\/j.amjoto.2026.104871_bb0070","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S1470-2045(24)00100-1","article-title":"Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial","volume":"25","author":"Machiels","year":"2024","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.amjoto.2026.104871_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-019-0976-4","article-title":"Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis","volume":"18","author":"Wei","year":"2019","journal-title":"Mol Cancer"},{"key":"10.1016\/j.amjoto.2026.104871_bb0080","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","article-title":"Tumor-associated macrophages: from mechanisms to therapy","volume":"41","author":"Noy","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.amjoto.2026.104871_bb0085","first-page":"1","article-title":"Role of CD68 in tumor immunity and prognosis prediction in pan-cancer","volume":"12","author":"Zhang","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.amjoto.2026.104871_bb0090","first-page":"3269","article-title":"Prognostic impact of CD68 and kallikrein 6 in human glioma","volume":"29","author":"Strojnik","year":"2009","journal-title":"Anticancer Res"},{"key":"10.1016\/j.amjoto.2026.104871_bb0095","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1016\/j.thromres.2011.10.027","article-title":"Co-localization of protein Z, protein Z-dependent protease inhibitor and coagulation factor X in human colon cancer tissue: implications for coagulation regulation on tumor cells","volume":"129","author":"Sierko","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.amjoto.2026.104871_bb0100","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1016\/S0049-3848(20)30406-0","article-title":"Coagulation signaling and cancer immunotherapy","volume":"191","author":"Ruf","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.amjoto.2026.104871_bb0105","first-page":"1","article-title":"Coagulation factor X regulated by CASC2c recruited macrophages and induced M2 polarization in glioblastoma multiforme","volume":"9","author":"Zhang","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.amjoto.2026.104871_bb0110","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and cancer: triggers, mechanisms, and consequences","volume":"51","author":"Greten","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.amjoto.2026.104871_bb0115","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1007\/s00262-020-02604-w","article-title":"PD-L1 expression correlates with tumor-infiltrating lymphocytes and better prognosis in patients with HPV-negative head and neck squamous cell carcinomas","volume":"69","author":"Sanchez-Canteli","year":"2020","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.amjoto.2026.104871_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118798","article-title":"Tumor-regulated macrophage type 2 differentiation promotes immunosuppression in laryngeal squamous cell carcinoma","volume":"267","author":"Zhang","year":"2021","journal-title":"Life Sci"},{"key":"10.1016\/j.amjoto.2026.104871_bb0125","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa0905680","article-title":"Tumor-associated macrophages and survival in classic Hodgkin\u2019s lymphoma","volume":"362","author":"Steidl","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjoto.2026.104871_bb0130","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1677\/ERC-08-0036","article-title":"Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer","volume":"15","author":"Ryder","year":"2008","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.amjoto.2026.104871_bb0135","doi-asserted-by":"crossref","DOI":"10.1177\/1533033819874807","article-title":"Elevated levels of TNF-\u03b1 and decreased levels of CD68-positive macrophages in primary tumor tissues are unfavorable for the survival of patients with nasopharyngeal carcinoma","volume":"18","author":"Yu","year":"2019","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.amjoto.2026.104871_bb0140","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S1470-2045(16)00078-4","article-title":"Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial","volume":"17","author":"Nywening","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.amjoto.2026.104871_bb0145","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1007\/s10637-012-9869-8","article-title":"Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer","volume":"31","author":"Pienta","year":"2013","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.amjoto.2026.104871_bb0150","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1186\/s12885-023-10775-9","article-title":"Evaluating the prognostic significance of p53 and TP53 mutations in HPV-negative hypopharyngeal carcinoma patients: a 5-year follow-up retrospective study","volume":"23","author":"Huang","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.amjoto.2026.104871_bb0155","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/lio2.443","article-title":"Prognostic role of human papilloma virus status in hypopharyngeal squamous cell carcinoma","volume":"5","author":"Marshall","year":"2020","journal-title":"Laryngoscope Investig Otolaryngol"},{"key":"10.1016\/j.amjoto.2026.104871_bb0160","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.oraloncology.2015.11.004","article-title":"Regional control is preserved after dose de-escalated radiotherapy to involved lymph nodes in HPV positive oropharyngeal cancer","volume":"53","author":"Woody","year":"2016","journal-title":"Oral Oncol"},{"key":"10.1016\/j.amjoto.2026.104871_bb0165","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1200\/JCO.23.01308","article-title":"Hypoxia-directed treatment of human papillomavirus\u2013related oropharyngeal carcinoma","volume":"42","author":"Lee","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.amjoto.2026.104871_bb0170","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1001\/jamaoncol.2022.0615","article-title":"Assessment of toxic effects and survival in treatment deescalation with radiotherapy vs transoral surgery for HPV-associated oropharyngeal squamous cell carcinoma: the ORATOR2 phase 2 randomized clinical trial","volume":"8","author":"Palma","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.amjoto.2026.104871_bb0175","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(18)32752-1","article-title":"Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial","volume":"393","author":"Mehanna","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.amjoto.2026.104871_bb0180","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1200\/JCO.24.00119","article-title":"Radiotherapy versus transoral robotic surgery for oropharyngeal squamous cell carcinoma: final results of the ORATOR randomized trial","volume":"42","author":"Nichols","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.amjoto.2026.104871_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-80226-z","article-title":"Tumour inflammation signature and expression of S100A12 and HLA class I improve survival in HPV-negative hypopharyngeal cancer","volume":"11","author":"Mints","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.amjoto.2026.104871_bb0190","doi-asserted-by":"crossref","first-page":"861","DOI":"10.3892\/or_00000717","article-title":"HLA class I antigen and transporter associated with antigen processing downregulation in metastatic lesions of head and neck squamous cell carcinoma as a marker of poor prognosis","volume":"23","author":"Bandoh","year":"2010","journal-title":"Oncol Rep"}],"container-title":["American Journal of Otolaryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196070926000864?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196070926000864?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T16:21:06Z","timestamp":1784391666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196070926000864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0196070926000864"],"URL":"https:\/\/doi.org\/10.1016\/j.amjoto.2026.104871","relation":{},"ISSN":["0196-0709"],"issn-type":[{"value":"0196-0709","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The inflammatory microenvironment in patients with advanced and relapsing hypopharyngeal squamous cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"American Journal of Otolaryngology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjoto.2026.104871","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104871"}}